WM, v. O., EM, H., EWN, L., IB, K., TP, S., REM, T., . . . CM, F. (2025). Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis. Arthritis & rheumatology (Hoboken, N.J.), 77(7), 901. https://doi.org/10.1002/art.43099
Chicago Style (17th ed.) CitationWM, van Oostveen, Hoekstra EM, Levarht EWN, Kotliar IB, Sakmar TP, Toes REM, de Vries-Bouwstra JK, Heitman LH, and Fehres CM. "Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis." Arthritis & Rheumatology (Hoboken, N.J.) 77, no. 7 (2025): 901. https://doi.org/10.1002/art.43099.
MLA (9th ed.) CitationWM, van Oostveen, et al. "Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis." Arthritis & Rheumatology (Hoboken, N.J.), vol. 77, no. 7, 2025, p. 901, https://doi.org/10.1002/art.43099.